Skip to content

Clinical trials

Overweight trials in France

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Overweight Country / region: France Clear all

92 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20041
20053
20061
20071
20082
20091
20101
20113
20124
20131
20144
20154
20164
20174
20184
20195
20202
20214
20225
20234
20243
202516
202613

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed45
Recruiting15
Unknown status12
Not yet recruiting9
Active, not recruiting7
Terminated4

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
University Hospital, Clermont-Ferrand8
Laboratoire des Adaptations Métaboliques à l'Exercice en conditions Physiologiques et Pathologiques7
Eli Lilly and Company5
Novo Nordisk A/S5
University Hospital, Montpellier5
Central Hospital, Nancy, France4
Centre Hospitalier Universitaire Dijon4
Hospices Civils de Lyon4
Institut National de Recherche pour l'Agriculture, l'Alimentation et l'Environnement4
Assistance Publique - Hôpitaux de Paris3

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Overweight92
Obesity70
Diabetes Mellitus, Type 28
Metabolic Syndrome4
Diabetes Mellitus, Type 13
Sleep Apnea, Obstructive3
Atherosclerosis2
Dyslipidemias2
Hypertriglyceridemic Waist2
Metabolic Diseases2

Trials

Showing 26 to 50 of 92. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.